GNMT

GNMT is a tetrameric S-adenosylmethionine (SAM)-dependent methyltransferase that catalyzes methyl transfer from SAM to glycine, producing sarcosine and S-adenosylhomocysteine (SAH), and thereby serves as a critical regulator of the cellular SAM/SAH ratio, folate metabolism, nucleotide biosynthesis, and epigenetic methylation. Structurally a homotetramer with a central channel, GNMT functions as a major hepatic folate-binding protein that promotes folate retention, methionine synthase-dependent homocysteine remethylation, and folate-dependent pyrimidine and purine synthesis, with its loss causing uracil misincorporation into DNA (PMID:9655336, PMID:21210071, PMID:23922098). GNMT suppresses AKT signaling by interacting with PREX2 and promoting its HectH9-mediated proteasomal degradation, regulates mitochondrial Complex II activity, and undergoes phosphorylation-dependent (Ser9, via PKC/JNK) nuclear translocation in response to genotoxic stress (PMID:28205209, PMID:31668391, PMID:30987732). GNMT expression is transcriptionally repressed by MYC, post-transcriptionally suppressed by miR-873-5p, and its protein levels are buffered through nuclear ubiquitin-proteasome-mediated degradation under SAM-limiting conditions; promoter polymorphisms that reduce GNMT expression are associated with hepatocellular carcinoma susceptibility (PMID:30760754, PMID:31668391, PMID:12566309).

1. 1998 High

   Determination of the crystal structure of GNMT resolved how four identical subunits assemble into the functional tetramer and identified the SAM-binding pocket architecture, establishing the structural basis for its methyl transfer mechanism.

   Evidence X-ray crystallography of apo-GNMT at 2.5 Å resolution with comparison to AdoMet-bound form

   PMID:9655336

   Open questions at the time

   • No structure of ternary complex with glycine substrate
   • Mechanism of inter-subunit allosteric communication unresolved
   • No structural basis for folate binding identified
2. 2003 Medium

   Functional characterization of GNMT promoter polymorphisms established that allele-specific variation in transcriptional output is linked to hepatocellular carcinoma risk, positioning GNMT as a tumor suppressor gene whose reduced expression contributes to liver carcinogenesis.

   Evidence Luciferase reporter and EMSA assays of promoter variants; loss-of-heterozygosity analysis in HCC tissues

   PMID:12566309

   Open questions at the time

   • Causal relationship between GNMT expression level and tumor initiation not demonstrated
   • No genome-wide association replication
   • Downstream oncogenic pathways linking reduced GNMT to HCC not defined
3. 2011 High

   Demonstration that GNMT is a major hepatic folate-binding protein resolved how it integrates one-carbon metabolism by increasing folate retention and promoting methionine synthase-dependent homocysteine remethylation.

   Evidence Stable isotopic tracing with GC/MS in GNMT transgenic and knockout mouse models; Western blot quantification of methionine synthase

   PMID:21210071

   Open questions at the time

   • Direct structural characterization of GNMT–folate binding interface absent
   • Relative contribution of GNMT folate-binding versus methyltransferase activity not separated
4. 2013 High

   Establishing that GNMT supports both pyrimidine and purine synthesis through folate-dependent pathways, and translocates to the nucleus during folate depletion, expanded its role from SAM metabolism to genome integrity maintenance.

   Evidence Isotopic tracing in GNMT-overexpressing cells and Gnmt KO mice; uracil content measurement in genomic DNA; nuclear localization assays

   PMID:23922098

   Open questions at the time

   • Nuclear function of GNMT beyond metabolic channeling undefined
   • Mechanism of folate-depletion-triggered nuclear import unknown at this stage
5. 2014 High

   Cross-species work in Drosophila revealed that GNMT is transcriptionally upregulated by FOXO in response to inflammatory stress to consume SAM and produce sarcosine, establishing GNMT as a metabolic rheostat during energy stress; in parallel, mouse studies showed GNMT deficiency activates NK cell–TRAIL/DR5 signaling to drive liver fibrosis.

   Evidence Drosophila fat body genetic epistasis with metabolomics; double-knockout mice (TRAIL/GNMT) with bile duct ligation

   PMID:24746817 PMID:25531568

   Open questions at the time

   • Whether FOXO-GNMT axis is conserved in mammalian liver not tested
   • How SAM depletion specifically activates NK cells in GNMT-null mice not established
6. 2017 High

   Discovery that GNMT physically interacts with PREX2 and promotes its HectH9-mediated ubiquitination and proteasomal degradation revealed a non-enzymatic tumor-suppressive function through suppression of AKT signaling.

   Evidence Reciprocal co-immunoprecipitation; siRNA depletion of GNMT and HectH9; AKT phosphorylation assays; GNMT KO mouse liver; IHC in human HCC

   PMID:28205209

   Open questions at the time

   • Whether GNMT methyltransferase activity is required for PREX2 interaction not tested
   • Structural basis of GNMT–PREX2–HectH9 tripartite complex unknown
   • Relative contribution of catalytic versus scaffolding tumor-suppressor functions unresolved
7. 2019 High

   Three contemporaneous studies resolved distinct regulatory layers: MYC directly binds the GNMT promoter to repress transcription; miR-873-5p post-transcriptionally represses GNMT to impair mitochondrial Complex II activity in NAFLD; and phosphorylation at Ser9 by PKC/JNK is required for genotoxic-stress-induced nuclear translocation.

   Evidence ChIP with anti-MYC on GNMT promoter, reporter assays, xenograft model; miR-873-5p target validation with Complex II activity assays in NAFLD models; LC-MS/MS phosphoproteomics with S9A mutagenesis and CYP1A1 readout

   PMID:30760754 PMID:30987732 PMID:31668391

   Open questions at the time

   • Mechanism by which GNMT regulates Complex II activity not molecularly defined
   • Whether nuclear GNMT has distinct substrates or functions beyond metabolic channeling unclear
   • Direct kinase assays for PKC/JNK phosphorylation of Ser9 not shown
8. 2020 Medium

   Identification of GNMT as a direct target of the dipeptide carnosine via CETSA demonstrated that small-molecule binding can modulate GNMT's SAM/SAH regulatory function to reduce renal inflammation and fibrosis in diabetic nephropathy.

   Evidence CETSA and molecular docking for direct binding; GNMT overexpression/knockdown in diabetic nephropathy mouse models

   PMID:33241846

   Open questions at the time

   • Binding site of carnosine on GNMT not structurally characterized
   • Whether carnosine modulates catalytic activity or protein stability not distinguished
   • Single-lab finding
9. 2024 Medium

   Work in Drosophila and macrophage models extended the regulatory framework: GNMT protein is degraded by nuclear UPS under SAM shortage to buffer SAM levels, and the AurA–FOXO3 axis controls GNMT expression to regulate SAM-dependent histone methylation and trained immunity.

   Evidence Drosophila nuclear UPS suppression with SAM measurement (preprint); AurA inhibitor treatment with ATAC-seq, ChIP for H3K4me3/H3K36me3, and metabolomics in macrophages (preprint)

   PMID:bio_10.1101_2024.08.21.609067 PMID:bio_10.1101_2024.11.11.622956

   Open questions at the time

   • Both studies are preprints awaiting peer review
   • E3 ligase responsible for nuclear GNMT degradation not identified
   • Whether GNMT-dependent histone methylation changes are direct or secondary to SAM pool depletion not resolved
10. 2025 Medium

    Demonstration that choline upregulates GNMT through an AMPK/MYC axis linked GNMT to hepatic lipid metabolism, bile acid metabolism, and lipoprotein assembly, broadening its physiological role beyond one-carbon metabolism.

    Evidence GNMT knockdown combined with AMPK inhibition; transcriptomic profiling of lipid and bile acid metabolism genes in hepatocytes

    PMID:41233636

    Open questions at the time

    • Direct enzymatic or metabolic mechanism connecting GNMT to lipid/bile acid pathways not defined
    • Single lab with limited molecular depth

• The structural basis of GNMT's non-catalytic interactions (PREX2, folate, Complex II), the identity of the E3 ligase mediating nuclear GNMT degradation in mammals, and whether nuclear GNMT has distinct substrates or chromatin-regulatory roles beyond SAM pool modulation remain unresolved.
• No structure of GNMT bound to PREX2 or folate
• No mammalian validation of nuclear UPS-mediated GNMT degradation
• Whether GNMT directly methylates nuclear substrates beyond glycine is untested